Sökresultat - Paul M. Ridker

Förfina resultatet
  1. 1
    Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates?

    Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates? av Paul M. Ridker

    Publicerad 2012
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)

    Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) av Paul M. Ridker

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    High-Sensitivity C-Reactive Protein

    High-Sensitivity C-Reactive Protein av Paul M. Ridker

    Publicerad 2001
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    On Evolutionary Biology, Inflammation, Infection, and the Causes of Atherosclerosis

    On Evolutionary Biology, Inflammation, Infection, and the Causes of Atherosclerosis av Paul M. Ridker

    Publicerad 2002
    Hämta fulltext
    Editorial
    Lägg till i favoriter
    Sparad:
  5. 5
    Inflammation, Infection, and Cardiovascular Risk

    Inflammation, Infection, and Cardiovascular Risk av Paul M. Ridker

    Publicerad 1998
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  6. 6
    Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

    Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention av Paul M. Ridker

    Publicerad 2003
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  7. 7
    Targeting inflammatory pathways for the treatment of cardiovascular disease

    Targeting inflammatory pathways for the treatment of cardiovascular disease av Paul M. Ridker

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  8. 8
    Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

    Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Prot... av Paul M. Ridker

    Publicerad 2003
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  9. 9
    Inflammation, C-Reactive Protein, and Cardiovascular Disease

    Inflammation, C-Reactive Protein, and Cardiovascular Disease av Paul M. Ridker

    Publicerad 2014
    Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  10. 10
    Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?

    Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test? av Paul M. Ridker

    Publicerad 2007
    Hämta fulltext Hämta fulltext
    Carta
    Lägg till i favoriter
    Sparad:
  11. 11
    From C-Reactive Protein to Interleukin-6 to Interleukin-1

    From C-Reactive Protein to Interleukin-6 to Interleukin-1 av Paul M. Ridker

    Publicerad 2016
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  12. 12
    A Test in Context

    A Test in Context av Paul M. Ridker

    Publicerad 2016
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  13. 13
    Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin

    Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin av Paul M. Ridker

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  14. 14
    How Common Is Residual Inflammatory Risk?

    How Common Is Residual Inflammatory Risk? av Paul M. Ridker

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk

    Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk av Paul M. Ridker

    Publicerad 2018
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  16. 16
    Anticytokine Agents

    Anticytokine Agents av Paul M. Ridker

    Publicerad 2019
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  17. 17
    From CANTOS to CIRT to COLCOT to Clinic

    From CANTOS to CIRT to COLCOT to Clinic av Paul M. Ridker

    Publicerad 2020
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?

    From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? av Paul M. Ridker

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention

    Targeting residual inflammatory risk: The next frontier for atherosclerosis treatment and prevention av Paul M. Ridker

    Publicerad 2023
    Hämta fulltext
    Editorial
    Lägg till i favoriter
    Sparad:
  20. 20
    High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease

    High-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease av Nader Rifai, Paul M. Ridker

    Publicerad 2001
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: